NLSP NLS Pharmaceutics

Watchlist

Close Dec 20 16:00 ET

Post 20:01 ET

4.62MMarket Cap-0.29P/E (TTM)

NLS Pharmaceutics Key Stats

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2023/H1	0.000 / 0.000	--
--	2022/H2	0.000 / 0.000	--
--	2022/H1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2023/H10.000 / 0.000--

--2022/H20.000 / 0.000--

--2022/H10.000 / 0.000--

--------

Unlock Free Earnings Estimates

Open Account

6-K: Report of foreign private issuer (related to financial reporting)

Dec 4 16:17 ET

6-K: Report of foreign private issuer (related to financial reporting)

Nov 15 17:03 ET

6-K: Report of foreign private issuer (related to financial reporting)

Nov 12 16:06 ET

6-K: Report of foreign private issuer (related to financial reporting)

Nov 5 08:01 ET

Overall

No Data